Literature DB >> 32416455

Evaluation of protein arginine deiminase-4 inhibitor in TNBS- induced colitis in mice.

Tingting Zhang1, Yinliu Mei1, Wanfa Dong1, Jingxun Wang1, Fengjie Huang1, Jie Wu2.   

Abstract

BACKGROUND AND AIM: Many evidences indicated that neutrophil extracellular traps (NETs) are involved in the pathogenesis of inflammatory bowel disease (IBD). Citrullination of histones by Protein Arginine Deiminase-4 (PAD4) is central for NETs formation. This paper aimed to explore the definite role of NETs in mouse model of Crohn's disease (CD) with 2,4,6-trinitrobenzene sulfonic acid (TNBS).
METHODS: The expression of NETs-associated proteins and mRNAs in colon tissue were detected by immunohistochemistry and Real-time Quantitative PCR (QPCR) respectively. Neutrophils were isolated and stimulated in vitro to form NETs. In addition, we also administered Cl-amidine, PAD4 inhibitor, resulting in less NETs formation to investigate protective effect by measuring weight loss, gross bleeding, colon length, myeloperoxidase (MPO) activity, and cytokine expression in mice.
RESULTS: The results showed enhanced expression of Ly6G, citrullinated histone H3 (CitH3), and PAD4 in TNBS-induced colitis mice and higher ability of neutrophil to produce NETs in vitro. Blocking NETs formation through Cl-amidine effectively alleviated the clinical colitis index and tissue inflammation in TNBS mice, regulated the expression of pro- or anti-inflammatory cytokines. In addition, Cl-amidine reduced the gene expression of PAD4 and the expression of NETs-associated proteins in the colon of TNBS mice and inhibited the formation of NETs in vitro.
CONCLUSIONS: Our data showed that Cl-amidine could alleviate the clinical colitis index in TNBS mice to some extend and suggested blocking NETs formation through inhibition of PAD4 as therapeutic targets for the treatment of CD.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  2,4,6-trinitrobenzene sulfonic acid; Cl-amidine; Neutrophil extracellular traps; Protein arginine deiminase-4

Mesh:

Substances:

Year:  2020        PMID: 32416455     DOI: 10.1016/j.intimp.2020.106583

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  7 in total

Review 1.  The emerging role of neutrophilic extracellular traps in intestinal disease.

Authors:  Feng Chen; Yongqiang Liu; Yajing Shi; Jianmin Zhang; Xin Liu; Zhenzhen Liu; Jipeng Lv; Yufang Leng
Journal:  Gut Pathog       Date:  2022-06-22       Impact factor: 5.324

2.  Neutrophil Extracellular Traps: New Aspects.

Authors:  N V Vorobjeva
Journal:  Moscow Univ Biol Sci Bull       Date:  2021-02-08

3.  Investigation of H2S Donor Treatment on Neutrophil Extracellular Traps in Experimental Colitis.

Authors:  Szilvia Török; Nikoletta Almási; Zsuzsanna Valkusz; Anikó Pósa; Csaba Varga; Krisztina Kupai
Journal:  Int J Mol Sci       Date:  2021-11-25       Impact factor: 5.923

Review 4.  Molecular mechanisms and therapeutic target of NETosis in diseases.

Authors:  Jiayu Huang; Weiqi Hong; Meihua Wan; Limin Zheng
Journal:  MedComm (2020)       Date:  2022-08-19

Review 5.  The Citrullination-Neutrophil Extracellular Trap Axis in Chronic Diseases.

Authors:  Martin Maronek; Roman Gardlik
Journal:  J Innate Immun       Date:  2022-03-09       Impact factor: 7.111

Review 6.  PAD Inhibitors as a Potential Treatment for SARS-CoV-2 Immunothrombosis.

Authors:  Willie Elliott; Maheedhara R Guda; Swapna Asuthkar; Narasaraju Teluguakula; Durbaka V R Prasad; Andrew J Tsung; Kiran K Velpula
Journal:  Biomedicines       Date:  2021-12-09

7.  Neutrophil Extracellular Traps Caused by Gut Leakage Trigger the Autoimmune Response in Nonobese Diabetic Mice.

Authors:  Qi You; Yiming Shen; Yiling Wu; Yuyan Li; Chang Liu; Fengjie Huang; Harvest F Gu; Jie Wu
Journal:  Front Immunol       Date:  2022-01-17       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.